Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Oct-13 5:24 PM View:  | Altig Anthony E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 20,000 | $10.75 | $215,000.00 | (100%) 20.0K to 0 | |
| 28-Oct-13 7:51 PM View: | Schaum Meredith Gen Counsel and Chief Comp Off | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 2,937 | $10.75 | $31,572.80 | (100%) 2.94K to 0 | |
| 28-Oct-13 2:20 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 17,500 | $10.75 | $188,125.00 | (27%) 63.65K to 46.15K | |
| 28-Oct-13 2:43 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 441,761 | $10.75 | $4,748,930.00 | (100%) 441.76K to 0 | |
| 28-Oct-13 5:10 PM View: | McKinnell Henry A CEO and Chairman of the Board Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 25,000 | $10.75 | $268,750.00 | (100%) 25.0K to 0 | |
| 28-Oct-13 5:42 PM View: | Gorbach Md Sherwood SVP, Chief Scientific Officer | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 42,219 | $10.75 | $453,854.00 | (100%) 42.22K to 0 | |
| 28-Oct-13 3:05 PM View: | Auerbach Mark Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 20,000 | $10.75 | $215,000.00 | (100%) 20.0K to 0 | |
| 28-Oct-13 3:22 PM View: | Zerbe Robert L Md Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 15,000 | $10.75 | $161,250.00 | (100%) 15.0K to 0 | |
| 28-Oct-13 2:20 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 46,154 | $10.75 | $496,156.00 | (100%) 46.15K to 0 | |
| 28-Oct-13 4:50 PM View: | Newman Stephen L Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 7,500 | $10.75 | $80,625.00 | (100%) 7.5K to 0 | |
| 28-Oct-13 3:52 PM View: | Grebow Peter E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 15,000 | $10.75 | $161,250.00 | (100%) 15.0K to 0 | |
| 28-Oct-13 7:39 PM View: | Sirota Eric Chief Operating Officer | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 2,129 | $10.75 | $22,886.80 | (100%) 2.13K to 0 | |
| 28-Oct-13 5:57 PM View: | Webster Stephen W Chief Financial Officer | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 25,000 | $10.75 | $268,750.00 | (100%) 25.0K to 0 | |
| 28-Oct-13 2:43 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 1,026,960 | $10.75 | $11,039,800.00 | (70%) 1.47M to 441.76K | |
| 28-Oct-13 5:10 PM View: | McKinnell Henry A CEO and Chairman of the Board Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Oct-13 | Disposition | 10,000 | $10.75 | $107,500.00 | 67% 15.0K to 25.0K | |
| 06-Sep-13 1:40 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 04-Sep-13 | Option Exercise | 178,000 | $8.59 | $1,529,480.00 | 11% 1.62M to 1.8M | |
| 06-Sep-13 1:40 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 04-Sep-13 | Option Exercise | 103,615 | $9.01 | $933,205.00 | 6% 1.8M to 1.9M | |
| 17-May-13 7:29 PM View: | Schaum Meredith Gen.Counsel and Chief Comp Off | Optimer Pharmaceuticals, Inc. (OPTR) | 15-May-13 | Acquisition (other) | 1,789 | $7.53 | $13,473.00 | 100% 0 to 1.79K | |
| 13-May-13 9:37 PM View: | Sirota Eric Chief Operating Officer | Optimer Pharmaceuticals, Inc. (OPTR) | 09-May-13 | Grant | 10,000 | -- | -- | 470% 2.13K to 12.13K | |
| 25-Apr-13 12:14 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 23-Apr-13 | Option Exercise | 117,263 | $1.08 | $127,043.00 | 16% 731.69K to 848.96K | |
| 11-Apr-13 1:31 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 09-Apr-13 | Option Exercise | 103,125 | $12.34 | $1,272,560.00 | 16% 628.57K to 731.69K | |
| 10-Apr-13 9:59 PM View: | Lichtinger Pedro | Optimer Pharmaceuticals, Inc. (OPTR) | 08-Apr-13 | Market Option Sale | 148,000 | $14.69 | $2,173,990.00 | (59%) 252.08K to 104.08K | 13% |
| 10-Apr-13 9:59 PM View: | Lichtinger Pedro | Optimer Pharmaceuticals, Inc. (OPTR) | 08-Apr-13 | Option Exercise | 148,000 | $12.69 | $1,877,680.00 | 142% 104.08K to 252.08K | |
| 05-Apr-13 8:01 PM View: | Chang Michael N Director | Optimer Pharmaceuticals, Inc. (OPTR) | 03-Apr-13 | Option Exercise | 145,312 | $12.34 | $1,793,150.00 | 30% 483.26K to 628.57K | |
| 28-Feb-13 9:42 PM View: | Auerbach Mark Director | Optimer Pharmaceuticals, Inc. (OPTR) | 26-Feb-13 | Grant | 2,500 | -- | -- | 14% 17.5K to 20.0K | |
| 03-Jan-13 4:30 PM View: | Zerbe Robert L Md Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 100% 7.5K to 15.0K | |
| 03-Jan-13 4:30 PM View: | Newman Stephen L Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 03-Jan-13 4:28 PM View: | Grebow Peter E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 100% 7.5K to 15.0K | |
| 03-Jan-13 4:29 PM View: | McKinnell Henry A Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 10,000 | -- | -- | 40% 25.0K to 35.0K | |
| 03-Jan-13 4:26 PM View: | Altig Anthony E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 60% 12.5K to 20.0K | |
| 03-Jan-13 4:27 PM View: | Auerbach Mark Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 75% 10.0K to 17.5K | |
| 03-Jan-13 4:27 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-13 | Grant | 7,500 | -- | -- | 7% 102.31K to 109.81K | |
| 08-Mar-13 5:19 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Dec-12 | Gift | 46,152 | -- | -- | (45%) 102.31K to 56.15K | |
| 08-Mar-13 5:19 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 24-Dec-12 | Gift | 92,306 | -- | -- | (47%) 194.61K to 102.31K | |
| 19-Nov-12 7:31 PM View: | Lichtinger Pedro CEO and President | Optimer Pharmaceuticals, Inc. (OPTR) | 08-Nov-12 | Market Purchase | 11,000 | $9.08 | $99,847.00 | 12% 93.08K to 104.08K | 40% |
| 14-Aug-12 6:22 PM View: | Gorbach Md Sherwood Chief Scientific Officer, SVP | Optimer Pharmaceuticals, Inc. (OPTR) | 11-Aug-12 | Grant | 3,500 | -- | -- | 9% 38.72K to 42.22K | |
| 14-Aug-12 6:14 PM View: | Hartman Kurt M General Counsel, SVP | Optimer Pharmaceuticals, Inc. (OPTR) | 11-Aug-12 | Grant | 3,500 | -- | -- | 100% 0 to 3.5K | |
| 02-Jul-12 4:55 PM View: | Webster Stephen W CFO | Optimer Pharmaceuticals, Inc. (OPTR) | 29-Jun-12 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 20-Jun-12 8:42 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 11-Jun-12 | Market Option Sale | 3,461 | $15.30 | $52,953.30 | (3%) 105.77K to 102.31K | 17% |
| 20-Jun-12 8:42 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 11-Jun-12 | Option Exercise | 3,461 | $0.65 | $2,249.65 | 3% 102.31K to 105.77K | |
| 20-Jun-12 8:28 PM View: | McKinnell Henry A Director | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 10,000 | -- | -- | 67% 15.0K to 25.0K | |
| 20-Jun-12 8:13 PM View: | Altig Anthony E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 2,500 | -- | -- | 25% 10.0K to 12.5K | |
| 20-Jun-12 8:06 PM View: | Auerbach Mark Director | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 2,500 | -- | -- | 33% 7.5K to 10.0K | |
| 20-Jun-12 8:42 PM View: | Chang Joseph Y Director | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 2,500 | -- | -- | 3% 99.81K to 102.31K | |
| 25-Jun-12 4:57 PM View: | Zerbe Robert L Md Director | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 2,500 | -- | -- | 50% 5.0K to 7.5K | |
| 20-Jun-12 8:22 PM View: | Grebow Peter E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 31-May-12 | Grant | 2,500 | -- | -- | 50% 5.0K to 7.5K | |
| 17-May-12 1:23 PM View: | Lichtinger Pedro CEO and President Director | Optimer Pharmaceuticals, Inc. (OPTR) | 15-May-12 | Acquisition (other) | 2,185 | $9.72 | $21,246.90 | 2% 90.89K to 93.08K | |
| 17-May-12 1:58 PM View: | Papaz Gregory E. SVP, Commercial Operations | Optimer Pharmaceuticals, Inc. (OPTR) | 15-May-12 | Acquisition (other) | 998 | $9.72 | $9,704.55 | 63% 1.59K to 2.59K | |
| 17-May-12 1:38 PM View: | Gorbach Md Sherwood SVP, Chief Medical Officer | Optimer Pharmaceuticals, Inc. (OPTR) | 15-May-12 | Acquisition (other) | 531 | $9.72 | $5,163.44 | 1% 38.19K to 38.72K | |
| 03-Jan-12 7:29 PM View: | Altig Anthony E Director | Optimer Pharmaceuticals, Inc. (OPTR) | 01-Jan-12 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K |
